JPRN-UMIN000010200招募中2 期
Phase II study of chemotherapy with Capecitabine/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer - Phase II study of chemotherapy with Capecitabine/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer
Yamafuchi University Medical Bioregulation Department of Organ Regulatory Surgery0 个研究点目标入组 30 人开始时间: 2013年3月11日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)active brain metastases (2) Complication of cerebrovascular disease or symptoms within 1 year (3) Patient receiving surgical procedure or such as skin-open biopsy, trauma surgery, or other more intensive surgeries within 4 weeks or aspiration biopsy within a week (4) History of gastrointestinal perforation within 1 year. (5) Uncontrollable peptic ulcer, Hypertension, diarrhea, infections (6) A bleeding tendency, coagulation disorder or abnormal coagulation factor (7) bleeding diathesis or receiving anticoagulant drug(except Aspirin under 325mg/day) (8) Serious heart disease (9) History of active double cancer within 5 years (10)History of the serious hypersensitivity for capecitabine or bevacizumab (11)Other conditions not suitable for this study
研究者
相似试验
进行中（未招募）
不适用
Phase II-Studie: Standardchemotherapie Capecitabin in Kombination mit Bevacizumab in der Erstlinientherapie beim metastasierten kolorektalen Karzinom - AIO KRK 0105EUCTR2005-001919-21-DEMartin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, endvertreten durch den Dekan80
招募中
不适用
Pilot Study of chemotherapy with Capecitabine,Oxaliplatin and Bevacizumab for pulmonary metastases from colorectal cancerPulmonary metastases from colorectal cancerJPRN-UMIN000004556Osaka International Cancer Institute20
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer - NDAdvanced or metastatic head and neck cancerLevel: HLTClassification code 10024530EUCTR2006-003775-13-ITOSPEDALE ONCOLOGICO DI BARI43
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer - NDEUCTR2006-003752-38-ITOSPEDALE ONCOLOGICO DI BARI
进行中（未招募）
不适用
Prospective phase II trial using Capecitabine and Trastuzumab for therapy of female patients with cerebral metastasizing, HER2-overexpressing breast cancer - HERXECNS-metastasizing HER2-overexpressing breast cancerMedDRA version: 9.1Level: PTClassification code 10057654Term: Breast cancer femaleMedDRA version: 9.1Level: PTClassification code 10006202Term: Breast cancer stage IVEUCTR2007-003634-42-DEKlinikum der Universität München, Standort Großhadern